Agreement signedPublished 15 Aug 2024

Genvara Biopharma, Inc. /
ARCA biopharma, Inc.

Genvara Biopharma to purchase ARCA’s legacy assets

Buy side: Genvara Biopharma, Inc.
Buy sideGenvara Biopharma, Inc.
Target: ARCA biopharma, Inc.
TargetARCA biopharma, Inc.
Source · 15 Aug 2024Source-verified
Buy side: Genvara Biopharma, Inc.
Buy sideGenvara Biopharma, Inc.
Target: ARCA biopharma, Inc.
TargetARCA biopharma, Inc.
01 / BuyerGenvara Biopharma, Inc.
02 / TargetARCA biopharma, Inc.
Source-verified
01

What happened

Genvara Biopharma, Inc. agreed to purchase assets from ARCA biopharma, Inc. related to its legacy Gencaro program for atrial fibrillation and rNAPc2 for COVID-19.

The agreement provides for a one-time cash payment of $300,000. The transaction closing is set to take effect immediately after the consummation of the First Merger.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Genvara Biopharma to purchase ARCA’s legacy assets

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.